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What is already known on this subject: 
• Exposures to endocrine-disrupting compounds like Bisphenol A and phthalates 
metabolites are widespread. 
• Studies have observed associations between exposures to these compounds and child 
BMI and adiposity, but results have been mixed. 
• Associations between exposures and child outcomes differ by sex. 
 
What this study adds: 
• Novel growth trajectory modelling allowed exploration of how exposures during 
pregnancy may influence child growth. 
• Boys and girls have different BMI trajectories depending on level of exposure in utero. 
• Highest predicted BMI in adolescence for girls occurred with the highest exposure, while 
the opposite was observed in boys.  




Background: Bisphenol A (BPA) and phthalates metabolites are linked to a variety of 
adverse health consequences, but studies have not explored their impact on growth 
trajectories. 
Objective: Explore body mass index (BMI) trajectories for tertile exposures to BPA and 
phthalates metabolites. 
Methods: We constructed BMI (kg/m2) trajectories from birth to 14 years in a birth cohort of 
249 children from Mexico City using tertiles of third trimester maternal urinary 
concentrations of BPA and phthalates metabolites. Fractional age polynomials and mixed 
effects models were fit separately by sex. Predicted models were plotted for each metabolite 
tertile with the covariates mother’s education and BMI centered at average values.  
Results: Highest predicted BMI trajectories for females were observed for third tertile 
exposure to the phthalate metabolite mono(2-ethyl-5-carboxypentyl) phthalate. In males, first 
tertile exposure to mono-isobutyl phthalate and monobenzyl phthalate and second tertile 
exposure to mono(2-ethylhexyl) phthalate and mono(2-ethyl-5-hydroxyhexyl) phthalate 
predicted the highest BMI trajectory by adolescence. There was no relationshsip between 
BPA and child growth trajectory. 
Conclusions: These results suggest sex-specific differences in BMI trajectories by levels of 
metabolite exposure. Additional studies are needed to consider growth through adolescence 
in assessing the impact of pregnancy exposures on child’s BMI. 
 
ABBREVIATIONS: 
BPA (bisphenol A); BMI (body mass index); INSP (Instituto Nacional de Salud Pública); 
CDC (Centers for Disease Control and Prevention); MEP (monoethyl phthalate); DEP 
(diethyl phthalate); MBP (mono-n-butyl phthalate); DBP (di-n-butyl phthalate); DiBP (di-
isobutyl-phthalate); MiBP (mono-isobutyl phthalate); MCPP (mono(3-carboxypropyl) 
phthalate); DOP (di-n-octyl phthalate); MBzP (monobenzyl phthalate); BBzP (butylbenzyl 
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phthalate); MEHP (mono(2-ethylhexyl) phthalate); MEHHP (mono(2-ethyl-5-hydroxyhexyl) 
phthalate); MEOHP (mono(2-ethyl-5-oxohexyl) phthalate); MECPP (mono(2-ethyl-5-
carboxypentyl) phthalate); DEHP (di(2-ethylhexyl) phthalate); SG (specific gravity); LOQ 
(limit of quantitation); AIC (Akaike information criterion); BIC (Bayesian information 
criterion)  
  




Childhood obesity is a globally persistent disease with multifactorial causes and a 
wide range of complications that track into adulthood 1. Increasingly, evidence suggests that 
exposures to environmental endocrine-disrupting compounds such as Bisphenol A (BPA) and 
phthalates may influence body weight and physiology, such as insulin resistance 2–4. These 
multi-functional compounds are used in everyday products, leading to ubiquitous exposure 
5,6. BPA is used in the production of polycarbonate plastics and epoxy resins and is 
commonly found in food and beverage containers, medical equipment, toys, the linings of 
canned foods, thermal receipt paper, and dental sealants 7. Phthalates are used similarly as 
plasticizers in many consumer and industrialized products and as a stabilizing and 
solubilizing material 8.  
Associations between exposures to these compounds and increased body mass index 
(BMI) and adiposity differ by sex, population, and age of exposure, but many studies suggest 
positive associations 9–12. However, no longitudinal studies have investigated the role that in 
utero exposures to these compounds may have on growth trajectories. By assessing whether 
growth differs by levels of exposure, this could allow estimation of milestones, such as 
infancy peak or the adiposity rebound, which could be used to link childhood growth with 
adult diseases like obesity 13.  
In this study, we add to our previously reported associations between in utero and 
childhood urinary concentrations of BPA and phthalates metabolites on childhood BMI and 
adiposity 12. We examined the BMI growth trajectories of children exposed to these 
compounds in utero to assess how different levels of exposures may influence growth. We 
applied an exploratory method of growth modeling to fit and assess the trajectories of BMI 
for males and females by tertiles of third trimester BPA and phthalates metabolites. 
METHODS 
Study population 
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 The Early Life in Mexico to ENvironmental Toxicants (ELEMENT; n = 249) is a 22-
year long research collaboration with Mexico’s Instituto Nacional de Salud Pública (INSP) 
that consists of 3 sequentially-enrolled birth cohorts from Mexico City serving low-to-
moderate income populations, recruited from 1997-2005, and described elsewhere 14. Briefly, 
women were recruited to ELEMENT to examine the influence of in utero exposures to 
environmental toxicants on child development and health. Similar exclusions were applied to 
all 3 cohorts including living outside of Mexico City, gestational diabetes, preeclampsia, or 
pregnancy-related hypertensive disorder. Across each of the 3 cohorts, women were recruited 
during the first trimester of pregnancy or at delivery. Follow-up of the cohorts were 
continuously maintained, with child measurements collected at each study visit when the 
children were 3, 6, and 12 months of age and then every 6 months until 60 months; these 
children were then maintained in follow-up with 1-3 additional observations when children 
ranged in age from 8-14 years, between 2006-2012, conducted by trained personnel. 
Maternal education was obtained from the interviewer-administered baseline questionnaire. 
The research protocols were approved by the Ethics and Research Committees of INSP in 
Mexico, and the Institutional Review Boards at Harvard University and University of 
Michigan Schools of Public Health and informed consent and assent of minors were provided 
by all participants prior to enrollment. 
Anthropometric measures 
Children’s weights and heights were taken by study personnel using established 
research protocols, in hospital gowns and without shoes 15. Weight (BAME Mod 420; 
Catálogo Médico) was measured to the nearest 0.1 kg and height (BAME Mod 420; Catálogo 
Médico) was measured to the nearest 0.1 cm. Duplicate measures were taken of heights and 
weights and, if intra-personal variability exceeded the measurement tolerance of 0.5 cm, an 
additional measurement was taken. The observed values were averaged. BMI was calculated 
as weight divided by height squared (kg/m2). 
Urinary BPA and phthalates metabolites 
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A spot (second morning void) urine sample was collected in sterile cups and was 
aliquoted an hour after collection and frozen at -20°C, from women during their third-
trimester visit (average gestational age of 34.06 weeks). These samples were then transferred 
to the project's research center and frozen at −80 °C and shipped to the University of 
Michigan for storage. Samples were analyzed for total (free + glucuronidated) BPA and 9 
phthalate metabolites by NSF International (Ann Arbor, MI, USA) using validated 
modification of the Centers for Disease Control and Prevention (CDC) methods described 
elsewhere 16. The 9 phthalate metabolites included: monoethyl phthalate (MEP), metabolite 
of diethyl phthalate (DEP); mono-n-butyl phthalate (MBP), metabolite of di-n-butyl 
phthalate (DBP); mono-isobutyl phthalate (MiBP), metabolite of di-isobutyl-phthalate 
(DiBP); mono(3-carboxypropyl) phthalate (MCPP), metabolite of DBP and di-n-octyl 
phthalate (DOP); monobenzyl phthalate (MBzP), metabolite of butylbenzyl phthalate 
(BBzP); and mono(2-ethylhexyl) phthalate (MEHP), mono(2-ethyl-5-hydroxyhexyl) 
phthalate (MEHHP), mono(2-ethyl-5-oxohexyl) phthalate (MEOHP), and mono(2-ethyl-5-
carboxypentyl) phthalate (MECPP), metabolites of di(2-ethylhexyl) phthalate (DEHP). 
Specific gravity (SG) of urine samples were measured using a handheld digital refractometer 
(ATAGO Company Ltd., Tokyo, Japan) and metabolite concentrations below the limit of 
quantitation (LOQ) were assigned a value of LOQ/sqrt(2).  
Individual metabolites were then corrected for SG, which takes urinary dilution into 
account, using: Pc = P[SGp-1)/(SGi-1)], where Pc is the SG-corrected BPA or phthalate 
metabolite concentration (ng/mL), P is the measured urinary BPA or phthalate metabolite 
concentration, SGi is the urinary specific gravity for the individual, and SGp is the median of 
the urinary specific gravities for the sample (SGp for mothers = 1.013).17 
 Covariates 
At 1 month postpartum, maternal weight and height was measured to the nearest 0.1 
kg and 0.1 cm, respectively (BAME Mod 420; Catálogo Médico). Sociodemographic 
characteristics of the mother were collected at the third trimester through questionnaires 
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administered by study personnel. Socioeconomic status was represented by the years of 
completed schooling by the mother at enrollment.  
Statistical analysis 
Data analysis was completed using SAS (version 9.3; SAS Institute, Cary, NC, USA). 
SG-corrected metabolites were natural log-transformed to normality prior to analyses. Each 
child had 5 to 12 observations for BMI; values were checked for biological implausibility by 
visually assessing their growth trajectory; values such as decreases in height were removed 
(n = 6 observations). 
We fit sex-stratified models to assess the differences in predicted BMI trajectories 
associated with exposure to tertiles of BPA and phthalate metabolites measured during the 
third trimester of pregnancy. Following an approach similar to published methods used to 
characterize children’s BMI trajectories 18, we fit mixed effects models with fixed effects 
using a fractional polynomial age approach 19. First, the optimal fractional polynomial to 
model the expected valued of BMI was selected from 
where m is the model degree and the exponential 𝑝𝑝𝑗 is selected from a set of 8 chosen values, 
which included -2, -1, -0.5, log, 0.5, 1, 2, and 3. The fewest number of terms in the model 
degree was set at m = 3 and the maximum degree was set to m = 8. Therefore, 219 candidate 
models were considered, with 1 model of the 8th degree, 8 models of the 7th degree, etc., and 
56 models of the 3rd degree. The optimal number of age terms were selected separately for 
males and females based on smallest Akaike information criterion (AIC) and Bayesian 
information criterion (BIC). All models contained random intercept and linear age to account 
for within-child correlation in the measures. Models for each sex are shown in 
Supplementary Table 1. 




This article is protected by copyright. All rights reserved.
9 
 
Second, for BPA and the 9 phthalates metabolite, tertiles of the metabolites and their 
interaction terms with the selected age variables were entered as fixed effects. Likelihood 
ratio tests were conducted with the null model containing the age polynomials and the a 
priori identified covariates mother’s years of schooling and BMI at 1 month postpartum 
centered at their means, against the fully-adjusted model additionally containing the SG-
corrected metabolites and their interaction terms with the age polynomials. Estimated model 
coefficients from fully-adjusted models were used to obtain predicted BMI trajectories for 
ages 0.25 to 13.8 years for each tertile of exposure when p < 0.05 from the likelihood ratio 
test. These plots demonstrate the estimated BMI trajectories for each tertile of the phthalate 
metabolite or BPA exposure for an individual with otherwise average characteristics.  
RESULTS 
 Among 249 children, 47% were male (Table 1). The average follow-up for children 
was 10.3 years. Among 2,162 total visits, 78% occurred at or before 5 years of age. 
Distributions of BPA and phthalate metabolites in maternal third trimester urine show 
detectable concentrations in most pregnancy samples, with no differences by sex 
(Supplementary Table 2). 
 We constructed BMI trajectories for models that showed a better fit with the inclusion 
of the BPA or phthalates metabolite (Supplementary Table 3). In boys, the likelihood ratio 
tests showed a better fit for models including the phthalates metabolites MiBP, MBzP, 
MEHP, and MEHHP. In girls, model fit was best with the inclusion of MECPP. We did not 
find a relationship between BPA exposure and BMI trajectories. 
Trajectories for each tertile of metabolite exposure crossed at various times during the 
modeled ages, particularly in the first few years. Some BMI trajectories which appeared to be 
stable at the highest trajectory, such as the second tertile of exposure to MiBP in boys, did 
not remain so after the age of 5 years. Conversely, while exposure to the highest tertile of 
MEHP in infancy predicted the highest BMI trajectory in boys, after age 2 the highest 
trajectory was predicted by exposure to the second tertile of MEHP exposure. Confidence 
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intervals widened as ages increased due to fewer observations. For modeled trajectories in 
boys, by age 14 the first and second tertiles of exposure had the highest predicted BMI 
trajectory (Figure 1). Exposure to the first tertile of MiBP and MBzP predicted the lowest 
BMI trajectory in infancy and early childhood, but crossed over to predict the highest BMI 
by age 14. With the phthalates metabolites MEHP and MEHHP, the second tertile of 
exposure was consistently predictive of the highest BMI trajectory from early childhood on. 
In girls, modeling showed that, by age 14, the third tertile of MECPP predicted the highest 
BMI trajectory for girls, though prior to age 9, the highest level of exposure predicted the 
lowest BMI trajectory (Figure 2).  
DISCUSSION 
 In this prospective study modeling BMI trajectories, we observed that in utero 
exposure to phthalates metabolites differentially influenced the BMI trajectories of boys and 
girls. While tertile trajectories crossed frequently in early childhood, by age 14, we found 
that different tertiles of exposure predicted the highest attained BMI. This was observed with 
the highest tertile of exposure in girls, but the first or second tertile of exposure in boys. We 
did not detect any significant association with BPA. 
 Previous studies have found some positive associations between BPA and phthalates 
metabolites with child BMI; most longitudinal studies have outcomes in early childhood with 
few occurring in late childhood and early adolescence 11,12,20–23. Results from these 
longitudinal studies have been mixed, with differences reported by metabolites, sex, and age. 
The mixed findings from prenatal exposures and child BMI outcomes may be due to the 
different ages that child outcomes are measured, which may be influenced by the timing of 
puberty or adiposity rebound. Therefore, we explored the use of growth trajectories as an 
alternate method of assessing the potential impact of early life exposures. The fluctuating 
trajectories indicated that the age outcomes are assessed at can influence the interpretation of 
the relationship between levels of exposures with child outcome. This is likely a contributing 
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reason why some metabolites are positively associated with child BMI at one age but not 
another.  
This is illustrated by contrasting the results we obtained here with previous work by 
others. Deierlein et al. (2016) observed higher BMI for girls aged 7-13 years when they were 
exposed at 6-8 years to medium vs. low concentrations of MBzP while, in previous work, we 
found an negative relationship between prenatal MBzP exposure and child’s BMI at ages 8-
14 years with no modification by sex 10,12. However, we only observed a relationship with 
MBzP among boys in this study. Similarly, a pooled analysis of 3 prospective cohorts in the 
US showed sexually dimorphic associations with high molecular weight phthalates 
metabolites (MEHP, MEHHP, MEOHP, MECPP) negatively associated with BMI in girls, 
but no associations with boys 24. In previous work, we found urinary concentrations of 
MEHP in boys were negatively associated with child adiposity but did not find a relationship 
among girls 12. This was inconsistent with other studies which observed MEHP to be 
inversely associated with BMI in girls both cross-sectionally and longitudinally 9,10. Using 
BMI trajectory modeling to re-assess our findings of MEHP exposure in utero, we found a 
relationship among boys, but not girls. These differences in results may potentially be due to 
the close trajectory paths and overlapping confidence intervals. However, with further 
refinement, growth trajectory modeling could be a useful tool to assess how exposures may 
alter trajectories of growth in children and may aid in interpreting how different levels of 
exposures may result in different associations. 
 The observed sex differences are thought to be due to the endocrine-disrupting 
mechanisms of phthalates metabolites. Phthalates are anti-androgenic and are able to 
influence energy homeostasis through increasing the number of adipocytes, as well as 
increasing lipid accumulation; their action is not through direct interaction with the androgen 
receptors, but through stimulation of the peroxisome proliferator-activated receptors family 
of nuclear receptors (PPARs) 8,25. PPARα in particular has been found to have sex-
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differential effects, with exposure to MEHP significantly increasing body weight and fat pads 
of male, but not female mice 26. 
Limitations of this study include the relatively small sample size and fewer number of 
observations of BMI measures after the age of 5, as follow-up was not systematic after that 
point in time. Children had 1-3 measurements after that age and few (n = 21) had only 1 
measurement after the age of 5. This modeling is exploratory in examining whether growth 
trajectories could be constructed using available data. Restricting growth modeling to 
observations before the age of 5 would have altered reported results and any further work 
will need to ensure greater data support for more precise modeling. Our interpretations 
should therefore be viewed with caution until further studies are conducted with more 
observations. We also chose to use fractional age polynomials rather than splines to model 
growth trajectories; spline models are more flexible but require pre-defined decisions on the 
number and placement of age knots as well as requiring continuous data support, whereas we 
wanted to explore how growth curves would form based on the data and much of our data on 
BMI was collected before the age of 5. 
Another limitation was the use of a single spot urine in pregnancy for analyses of 
metabolites. Concentrations of metabolites are known to have short metabolic half-lives, with 
<24 hours for phthalates metabolites and <5-6 hours for BPA, and exhibit temporal 
variability; a single spot measure may therefore not be capable of accurately assessing 
individuals 27,28. However, individuals tend to exhibit consistent behaviors that would result 
in more consistent exposures, which has been shown by other studies 29. Our geometric mean 
urinary concentrations of metabolites were comparable or lower compared with those 
reported by others in the pregnancy period. In a Californian population, Harley et al. (2013) 
reported a GM of 1.2 ng/mL for BPA averaged across 2 pregnancy time points, which was 
higher than our 0.7 ng/mL and 0.9 ng/mL for boys and girls, respectively. Similarly, higher 
values were reported by Vafeiadi et al. (2016) among a Greek population during the first 
trimester of pregnancy (1.2 ng/mL). For phthalates metabolites, higher GM values were 
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reported by Buckley et al. (2016) among 3 pooled cohorts from the US (µg/L; MEP: 154.1; 
MiBP: 6.45; MCPP: 2.08; MBzP: 11.6; MECPP: 35.7; MEHHP: 21.4; MEHP: 4.92; 
MEOHP: 18.0) and by Bellavia et al. (2017) among women in their first trimester of 
pregnancy in Boston (µg/L; MEP: 137.8; MEP: 0.9; MCPP: 2.1). While prenatal exposure to 
BPA was positively associated with BMI z-score in boys, but negatively in girls, at 4 years of 
age in the Rhea cohort 21,we did not find any differences in BMI trajectories by levels of 
BPA exposure, which may be due to the high proportion of values measured <LOQ. It is also 
possible that trimester-specific associations may reveal vulnerable windows for in utero 
exposures, but there are too few studies with trimester-specific exposures to draw any 
conclusions. Additionally, we also chose to correct for specific gravity, rather than creatinine,  
when controlling for urinary dilution, as creatinine is influenced by factors such as age, sex, 
and muscle mass 30.  
Exposures to BPA and phthalates metabolites are influenced by a variety of factors 
such as diet, physical activity, and use of personal care products. We did not include dietary 
intakes, consumer product use, or physical activity as potential confounders, which will 
impact the amount of residual confounding. We also relied on maternal BMI collected at 1 
month postpartum rather than prepregnancy BMI due to limited availability of self-reported 
heights and weights of the mothers at recruitment into the original birth cohorts.  
However, strengths of our study include the extensive follow-up within this 
prospective study design, allowing the construction of growth trajectories. Unlike cross-
sectional studies, where there is possibility of reverse causality from higher urinary 
metabolites in heavier individuals due to increased dietary intake or volume of consumer 
product use, longitudinal studies provide a temporal sequence of events and we were able to 
measure exposures in utero during a critical time of development. Additionally, the 
construction of BMI trajectories based on exposure in pregnancy is a novel method of 
assessing the potential impacts that these metabolites could have on child growth on a 
continuous scale, rather than exploring these associations at various ages.  




We found different levels of exposure to phthalates metabolites were associated with 
child growth by sex. In girls, the highest level of exposure to MECPP was associated with the 
highest predicted BMI by age 14, while lower levels of exposure to MiBP, MBzP, MEHP, 
and MEHHP were associated with the highest predicted BMI in boys. Our findings suggest 
that timing of outcome measurement may influence associations observed. Further follow-up 
in this study will provide us with anthropometric measures to capture trajectories through 
adolescence. Other studies are needed and should consider more evenly distributed 
measurements and confounding variables for growth modeling. Trajectory modeling is a 
potential method to better understand how exposures to endocrine-disrupting compounds 
may influence growth. 
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Table 1. Characteristics of mothers and children. 
Characteristics Males Females 
 
N Mean (SD)/% N Mean (SD)/% 
Child's age at last visit (yr) 117 10.3 (1.5) 132 10.3 (1.7) 
Child's BMI at last visit (kg/m2) 117 19.1 (3.08) 132 19.8 (3.98) 




  where age ≤1 years old 243 25 263 24 
  where age >1 and ≤3 years old 381 36 424 37 
  where age >3 and ≤5 years old 182 17 201 18 
  where age >5 years old 227 22 241 21 
Mother's BMI  114 26.7 (4.2) 126 27.2 (3.6) 
Mother's years of education 115 11.3 (2.8) 130 10.8 (2.8) 
 Abbreviations: SD (standard deviation)
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